PHAROS
DEAD

Serial Number

90542897

Owner

The PhAROS Institute, LLC

Attorney

Mark A. Jansen, Esq.

Filing Date

Feb 23, 2021

Add to watchlist:

No watchlists yet
View on USPTO

PHAROS Trademark

Serial Number: 90542897

PHAROS is a trademark filed by The PhAROS Institute, LLC on February 23, 2021. The trademark is classified under Class 9 (Computers & Electronics), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

The PhAROS Institute, LLC (2 trademarks)

3550 W. Teco Avenue
Las Vegas, NV 89118

Entity Type: 16

Trademark Details

Filing Date

February 23, 2021

Registration Date

Not Registered

Published for Opposition

November 15, 2022

Goods & Services

Medical services; treatment and diagnosis of medical diseases and conditions; providing medical therapy and treatments; providing medical therapy and treatments using plant-based and plant-derived preparations; providing an online medical database; medical assistance services; medical assistance services in the nature of medical information provided via the Internet, online databases, and global computer networks; international medical relief services; providing medical information about medicine and therapy

Educational services, namely, providing online non-downloadable videos, pamphlets, journals, and articles in the field of plant-based and plant-derived medicine and therapy; providing non-downloadable videos and multimedia content in the field of plant-based and plant-derived medicine and therapy

Downloadable software for tracking, categorizing, and analyzing various types of plants; downloadable software for tracking, categorizing, and analyzing plant-based and plant-derived medicines and therapies; downloadable software for mining databases of plant-based and plant derived medicines and treatments; downloadable software for collecting, processing, analyzing, transmitting, sharing, and validating information on the efficacy of plant-based and plant-derived medical treatments

Providing medical business consulting; business administration and management of health and medicine treatment programs; charitable services in the nature of coordination, organization, administration, and management of medical services and humanitarian assistance; promoting public awareness, knowledge, understanding and support of and for medical diseases and conditions

Providing a temporary use of non-downloadable software for tracking, organizing, categorizing, collecting, sharing, transmitting, and analyzing data in the field of plant-based and plant-derived medicines and therapies; platform as a service (PAAS) featuring software platforms for tracking, organizing, categorizing, collecting, sharing, transmitting, and analyzing data in the field of plant-based and plant-derived medicines and therapies; providing a temporary use of non-downloadable software for tracking, categorizing, and analyzing various types of plants; platform as a service (PAAS) featuring software platforms for tracking, categorizing, and analyzing various types of plants; providing a temporary use of non-downloadable software for tracking, categorizing, and analyzing plant-based and plant-derived medicines and therapies; platform as a service (PAAS) featuring software platforms for tracking, categorizing, and analyzing plant-based and plant-derived medicines and therapies; providing a temporary use of non-downloadable software for mining databases of plant-based and plant-derived medicines and treatments; platform as a service (PAAS) featuring software platforms for mining databases of medicines and treatments; providing a temporary use of non-downloadable software for collecting, processing, analyzing, transmitting, sharing, and validating information on the efficacy of plant-based and plant-derived medical treatments; platform as a service (PAAS) featuring software platforms for collecting, processing, analyzing, transmitting, sharing, and validating information on the efficacy of plant-based and plant-derived medical treatments; providing a temporary use of non-downloadable software for conducting a convergence analysis in the field of plant-based and plant-derived medicine; platform as a service (PAAS) featuring software platforms for conducting a convergence analysis in the field of plant-based and plant-derived medicine; research and development of plant-based or plant-derived therapeutics and preparations

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Feb 9, 2026 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Feb 9, 2026 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 4, 2025 EXRA
SOU EXTENSION 5 GRANTED
Nov 3, 2025 EX5G
SOU TEAS EXTENSION RECEIVED
Jun 16, 2025 EEXT
SOU EXTENSION 5 FILED
Jun 15, 2025 EXT5
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 23, 2025 EXRA
SOU EXTENSION 4 GRANTED
Jan 22, 2025 EX4G
SOU EXTENSION 4 FILED
Dec 16, 2024 EXT4
SOU TEAS EXTENSION RECEIVED
Dec 16, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 28, 2024 EXRA
SOU EXTENSION 3 GRANTED
Jun 28, 2024 EX3G
SOU EXTENSION 3 FILED
Jun 28, 2024 EXT3
SOU TEAS EXTENSION RECEIVED
Jun 28, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 20, 2023 EXRA
SOU EXTENSION 2 GRANTED
Dec 18, 2023 EX2G
SOU EXTENSION 2 FILED
Dec 18, 2023 EXT2
SOU TEAS EXTENSION RECEIVED
Dec 18, 2023 EEXT
REQUEST TO DIVIDE UNTIMELY, REFUSED, OR WITHDRAWN
Jun 9, 2023 UNTD
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jun 5, 2023 AITU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 12, 2023 EXRA
SOU EXTENSION 1 GRANTED
May 10, 2023 EX1G
SOU EXTENSION 1 FILED
May 10, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
May 10, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 10, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 15, 2022 NPUB
PUBLISHED FOR OPPOSITION
Nov 15, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 26, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 12, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 6, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 6, 2022 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Oct 6, 2022 ERFR
TEAS REQUEST TO DIVIDE RECEIVED
Oct 6, 2022 ERTD
NOTIFICATION OF FINAL REFUSAL EMAILED
Apr 6, 2022 GNFN
FINAL REFUSAL E-MAILED
Apr 6, 2022 GNFR
FINAL REFUSAL WRITTEN
Apr 6, 2022 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 19, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 18, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 18, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 20, 2021 GNRN
NON-FINAL ACTION E-MAILED
Sep 20, 2021 GNRT
NON-FINAL ACTION WRITTEN
Sep 20, 2021 CNRT
ASSIGNED TO EXAMINER
Sep 16, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 25, 2021 NWOS
NEW APPLICATION ENTERED
Feb 26, 2021 NWAP